AssureRx Health Inc., which sells a genetic test that helps doctors pick the right psychiatric drugs for patients based on their genes, has appointed a chief operating officer.
In addition to leading the company’s operations, Donald Wright Jr. will manage product development, information technology and external relationships, according to a statement from the Mason, Ohio-based company.
The company credited Wright with being “instrumental” in developing its GeneSightRx test, which uses a cheek swab, mathematical algorithms and bioinformatics to narrow drug choices to those that work with a patient’s genes. The company launched the test in 2009.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Future products from AssureRx might include tests that help doctors choose medications for patients who have neuro-degenerative diseases like Alzheimer’s or Parkinson’s, as well as disorders such as attention-deficit hyperactivity and post-traumatic stress.
The company also announced the hiring of John Bellano as senior vice president of sales and commercial programs.
